Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S De Marco

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I studyM Nardi, S De Marco, A Fabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II studyA Falcone, E Pfanner, S Ricci, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 1991
Clinical spectrum of accidental hemlock poisoning: neurotoxic manifestations, rhabdomyolysis and acute tubular necrosisD Rizzi, C Basile, A Di Maggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?P Carlini, A Frassoldati, S De Marco, et al.
Haematologica|September 1, 1995
Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liverP Mazza, R Giua, S De Marco, et al.
Haematologica|July 24, 1998
Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemiaP Mazza, B Amurri, G Lazzari, et al.
The American Journal of Cardiology|July 27, 2001
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery diseaseF Catella-Lawson, S Kapoor, D Moretti, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 20, 2004
The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II studyA Fabi, M Barduagni, V Ferraresi, et al.
Breast Cancer Research and Treatment|June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patientsC Nisticò, C Garufi, M Milella, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology|October 11, 2001
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I studyM Nardi, S De Marco, A Fabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II studyA Falcone, E Pfanner, S Ricci, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 1991
Clinical spectrum of accidental hemlock poisoning: neurotoxic manifestations, rhabdomyolysis and acute tubular necrosisD Rizzi, C Basile, A Di Maggio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable?P Carlini, A Frassoldati, S De Marco, et al.
Haematologica|September 1, 1995
Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liverP Mazza, R Giua, S De Marco, et al.
Haematologica|July 24, 1998
Oral iron chelating therapy. A single center interim report on deferiprone (L1) in thalassemiaP Mazza, B Amurri, G Lazzari, et al.
The American Journal of Cardiology|July 27, 2001
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery diseaseF Catella-Lawson, S Kapoor, D Moretti, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 20, 2004
The combination of carboplatin and weekly paclitaxel: a safe and active regimen in advanced non small-cell lung cancer patients. A phase I-II studyA Fabi, M Barduagni, V Ferraresi, et al.
Breast Cancer Research and Treatment|June 1, 2000
Weekly schedule of vinorelbine in pretreated breast cancer patientsC Nisticò, C Garufi, M Milella, et al.
Pageof 2